Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury
Spinal cord injury (SCI) is a devastating condition with limited therapeutic options despite decades of research. Current treatment options include use of steroids, surgery, and rehabilitation. Nevertheless, many patients with SCI remain disabled. MLC601 (NeuroAiD), a combination of natural products...
Saved in:
Published in | JMIR research protocols Vol. 5; no. 4; p. e230 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
JMIR Publications
05.12.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Spinal cord injury (SCI) is a devastating condition with limited therapeutic options despite decades of research. Current treatment options include use of steroids, surgery, and rehabilitation. Nevertheless, many patients with SCI remain disabled. MLC601 (NeuroAiD), a combination of natural products, has been shown to be safe and to aid neurological recovery after brain injuries and may have a potential role in improving recovery after SCI.
The aim of this study is to evaluate the safety and efficacy of NeuroAiD amongst people who sustain SCI in the study setting.
Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN) is a prospective cohort study of patients with moderately severe to severe SCI, defined as American Spinal Injury Association (ASIA) Impairment Scale (AIS) A and B. These patients will be treated with open-label NeuroAiD for 6 months in addition to standard care and followed for 24 months. Anonymized data will be prospectively collected at baseline and months 1, 3, 6, 12, 18, and 24 and will include information on demographics; main diagnostics; and neurological and functional state assessed by the Spinal Cord Independence Measure, ASIA-International Standard for Neurological Classification Spinal Cord Injury, and Short Form (SF-8) Health Survey. In addition, NeuroAiD treatment, compliance, concomitant therapies, and side effects, if any, will be collected. Investigators will use a secured online system for data entry. The study is approved by the ethics committee of Hospital University Kebangsaan Malaysia.
The coprimary endpoints are safety, AIS grade, and improvement in ASIA motor score at 6 months. Secondary endpoints are AIS grade, ASIA motor scores and sensory scores, Spinal Cord Independence Measure (SCIM), SF-8 Health Survey, and compliance at other time points.
SATURN investigates the promising role of NeuroAiD in SCI especially given its excellent safety profile. We described here the protocol and online data collection tool we will use for this prospective cohort study. The selection of moderately severe to severe SCI provides an opportunity to investigate the role of NeuroAiD in addition to standard rehabilitation in patients with poor prognosis. The results will provide important information on the feasibility of conducting larger controlled trials to improve long-term outcome of patients with SCI.
Clinicaltrials.gov NCT02537899; https://clinicaltrials.gov/ct2/show/NCT02537899 (Archived by WebCite at http://www.webcitation.org/6m2pncVTG). |
---|---|
AbstractList | Spinal cord injury (SCI) is a devastating condition with limited therapeutic options despite decades of research. Current treatment options include use of steroids, surgery, and rehabilitation. Nevertheless, many patients with SCI remain disabled. MLC601 (NeuroAiD), a combination of natural products, has been shown to be safe and to aid neurological recovery after brain injuries and may have a potential role in improving recovery after SCI.
The aim of this study is to evaluate the safety and efficacy of NeuroAiD amongst people who sustain SCI in the study setting.
Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN) is a prospective cohort study of patients with moderately severe to severe SCI, defined as American Spinal Injury Association (ASIA) Impairment Scale (AIS) A and B. These patients will be treated with open-label NeuroAiD for 6 months in addition to standard care and followed for 24 months. Anonymized data will be prospectively collected at baseline and months 1, 3, 6, 12, 18, and 24 and will include information on demographics; main diagnostics; and neurological and functional state assessed by the Spinal Cord Independence Measure, ASIA-International Standard for Neurological Classification Spinal Cord Injury, and Short Form (SF-8) Health Survey. In addition, NeuroAiD treatment, compliance, concomitant therapies, and side effects, if any, will be collected. Investigators will use a secured online system for data entry. The study is approved by the ethics committee of Hospital University Kebangsaan Malaysia.
The coprimary endpoints are safety, AIS grade, and improvement in ASIA motor score at 6 months. Secondary endpoints are AIS grade, ASIA motor scores and sensory scores, Spinal Cord Independence Measure (SCIM), SF-8 Health Survey, and compliance at other time points.
SATURN investigates the promising role of NeuroAiD in SCI especially given its excellent safety profile. We described here the protocol and online data collection tool we will use for this prospective cohort study. The selection of moderately severe to severe SCI provides an opportunity to investigate the role of NeuroAiD in addition to standard rehabilitation in patients with poor prognosis. The results will provide important information on the feasibility of conducting larger controlled trials to improve long-term outcome of patients with SCI.
Clinicaltrials.gov NCT02537899; https://clinicaltrials.gov/ct2/show/NCT02537899 (Archived by WebCite at http://www.webcitation.org/6m2pncVTG). BACKGROUNDSpinal cord injury (SCI) is a devastating condition with limited therapeutic options despite decades of research. Current treatment options include use of steroids, surgery, and rehabilitation. Nevertheless, many patients with SCI remain disabled. MLC601 (NeuroAiD), a combination of natural products, has been shown to be safe and to aid neurological recovery after brain injuries and may have a potential role in improving recovery after SCI. OBJECTIVEThe aim of this study is to evaluate the safety and efficacy of NeuroAiD amongst people who sustain SCI in the study setting. METHODSSpinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN) is a prospective cohort study of patients with moderately severe to severe SCI, defined as American Spinal Injury Association (ASIA) Impairment Scale (AIS) A and B. These patients will be treated with open-label NeuroAiD for 6 months in addition to standard care and followed for 24 months. Anonymized data will be prospectively collected at baseline and months 1, 3, 6, 12, 18, and 24 and will include information on demographics; main diagnostics; and neurological and functional state assessed by the Spinal Cord Independence Measure, ASIA-International Standard for Neurological Classification Spinal Cord Injury, and Short Form (SF-8) Health Survey. In addition, NeuroAiD treatment, compliance, concomitant therapies, and side effects, if any, will be collected. Investigators will use a secured online system for data entry. The study is approved by the ethics committee of Hospital University Kebangsaan Malaysia. RESULTSThe coprimary endpoints are safety, AIS grade, and improvement in ASIA motor score at 6 months. Secondary endpoints are AIS grade, ASIA motor scores and sensory scores, Spinal Cord Independence Measure (SCIM), SF-8 Health Survey, and compliance at other time points. CONCLUSIONSSATURN investigates the promising role of NeuroAiD in SCI especially given its excellent safety profile. We described here the protocol and online data collection tool we will use for this prospective cohort study. The selection of moderately severe to severe SCI provides an opportunity to investigate the role of NeuroAiD in addition to standard rehabilitation in patients with poor prognosis. The results will provide important information on the feasibility of conducting larger controlled trials to improve long-term outcome of patients with SCI. TRIAL REGISTRATIONClinicaltrials.gov NCT02537899; https://clinicaltrials.gov/ct2/show/NCT02537899 (Archived by WebCite at http://www.webcitation.org/6m2pncVTG). |
Author | Gan, Robert Abdul Rhani, Shaharuddin Htwe, Ohnmar Kumar, Ramesh Ariffin, Mohammad Hisam Ibrahim, Kamalnizat Rustam, Aishah Baharudin, Azmi |
AuthorAffiliation | 1 Department of Neurosurgery Faculty of Medicine University Kebangsaan Malaysia Medical Centre Kuala Lumpur Malaysia 3 Medical Affairs Moleac Biopolis Way Singapore 2 Department of Orthopaedics and Traumatology Faculty of Medicine University Kebangsaan Malaysia Medical Centre Kuala Lumpur Malaysia |
AuthorAffiliation_xml | – name: 2 Department of Orthopaedics and Traumatology Faculty of Medicine University Kebangsaan Malaysia Medical Centre Kuala Lumpur Malaysia – name: 3 Medical Affairs Moleac Biopolis Way Singapore – name: 1 Department of Neurosurgery Faculty of Medicine University Kebangsaan Malaysia Medical Centre Kuala Lumpur Malaysia |
Author_xml | – sequence: 1 givenname: Ramesh orcidid: 0000-0002-4979-9031 surname: Kumar fullname: Kumar, Ramesh organization: Department of Neurosurgery, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia – sequence: 2 givenname: Ohnmar orcidid: 0000-0001-6303-9859 surname: Htwe fullname: Htwe, Ohnmar organization: Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia – sequence: 3 givenname: Azmi orcidid: 0000-0003-1691-9102 surname: Baharudin fullname: Baharudin, Azmi organization: Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia – sequence: 4 givenname: Mohammad Hisam orcidid: 0000-0001-5200-8395 surname: Ariffin fullname: Ariffin, Mohammad Hisam organization: Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia – sequence: 5 givenname: Shaharuddin orcidid: 0000-0002-9810-3184 surname: Abdul Rhani fullname: Abdul Rhani, Shaharuddin organization: Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia – sequence: 6 givenname: Kamalnizat orcidid: 0000-0003-3626-2451 surname: Ibrahim fullname: Ibrahim, Kamalnizat organization: Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia – sequence: 7 givenname: Aishah orcidid: 0000-0002-2356-690X surname: Rustam fullname: Rustam, Aishah organization: Medical Affairs, Moleac, Biopolis Way, Singapore – sequence: 8 givenname: Robert orcidid: 0000-0003-0317-0374 surname: Gan fullname: Gan, Robert organization: Medical Affairs, Moleac, Biopolis Way, Singapore |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27919862$$D View this record in MEDLINE/PubMed |
BookMark | eNplks1u1DAURiNURH_ojjXyskikxE4cJywqRcMAlapSNTNiGTnOzYwrxw62UzVvzSOQMMNQhDe25OPvXEvfaXCkjYYgeIOjS4Lz9IMF11vjL1PC6IvgBOckDyOWZEfPzsfBuXMP0bQyxnKSvgqOCctxnqXkJPhZ9lJzhRbGNuhaPwx2DAvnwDmpN2hlFFheSyX9iLhu0NoBMu1Ed7XU0KB72O6uuZdG_0ZuYbCmkJ_QRVms1ve3qPRDM777iO6mQY0wag4oNFo-9cpY7o0dd8ikR3_Vfguo5C3sxcu2lYKLcX58MBSd0Rvn0R2YXgH6vjWoHJznUqMSHsFOCf_97nXwsuXKwfl-PwvWn5erxdfw5tuX60VxE4oYJz6kLM8yyijlGeWYUxLhqBbAmziHpiU1IXmU1QlmNWUsYpTFOBMxiCbCSd62OD4Lrna5_VB30AjQ3nJV9VZ23I6V4bL690bLbbUxjxXFaUbjdAq42AdY82MA56tOOgFKcQ1mcBXOkjRmGEez6_0OFdY4Z6E9aHBUzT2p9j2p5p5M-Nvnox3gP62IfwGYDsCG |
CitedBy_id | crossref_primary_10_3390_ijms21207533 crossref_primary_10_1080_10790268_2022_2067972 crossref_primary_10_1007_s44164_024_00070_7 |
Cites_doi | 10.1016/j.neuropharm.2011.05.003 10.1111/ijs.12324 10.1016/j.pneurobio.2013.11.002 10.1159/000155220 10.1159/000126919 10.1038/sj.sc.3102009 10.1159/000247001 10.1007/s11655-014-1687-8 10.1038/sc.2012.137 10.1159/000346231 10.1159/000313398 10.1016/j.neuropharm.2010.01.001 10.1159/000346228 10.1016/j.neuroscience.2014.06.047 10.3969/j.issn.1673-5374 10.1111/j.1747-4949.2009.00237.x 10.1016/j.ejim.2011.01.002 10.1155/2012/506387 10.1016/j.neuropharm.2012.05.035 10.1111/ijs.12044 10.4061/2011/721613 10.1038/sj.sc.3102007 10.1007/s11481-014-9570-0 10.1161/STROKEAHA.113.003226 10.1159/000382082 10.1161/STROKEAHA.108.531616 10.1016/j.jstrokecerebrovasdis.2014.11.017 10.1038/sc.2012.158 10.1038/sj.sc.3102008 10.1159/000346234 10.1038/sj.sc.3102010 10.1161/STROKEAHA.113.002055 |
ContentType | Journal Article |
Copyright | Ramesh Kumar, Ohnmar Htwe, Azmi Baharudin, Mohammad Hisam Ariffin, Shaharuddin Abdul Rhani, Kamalnizat Ibrahim, Aishah Rustam, Robert Gan. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 05.12.2016. Ramesh Kumar, Ohnmar Htwe, Azmi Baharudin, Mohammad Hisam Ariffin, Shaharuddin Abdul Rhani, Kamalnizat Ibrahim, Aishah Rustam, Robert Gan. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 05.12.2016. 2016 |
Copyright_xml | – notice: Ramesh Kumar, Ohnmar Htwe, Azmi Baharudin, Mohammad Hisam Ariffin, Shaharuddin Abdul Rhani, Kamalnizat Ibrahim, Aishah Rustam, Robert Gan. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 05.12.2016. – notice: Ramesh Kumar, Ohnmar Htwe, Azmi Baharudin, Mohammad Hisam Ariffin, Shaharuddin Abdul Rhani, Kamalnizat Ibrahim, Aishah Rustam, Robert Gan. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 05.12.2016. 2016 |
DBID | NPM AAYXX CITATION 7X8 5PM |
DOI | 10.2196/resprot.6275 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1929-0748 |
EndPage | e230 |
ExternalDocumentID | 10_2196_resprot_6275 27919862 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 7RV 7X7 8C1 8FI 8FJ AAFWJ ABUWG ADBBV ADRAZ AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU DIK FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M48 M~E NAPCQ NPM OK1 PGMZT PIMPY RPM UKHRP AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c314t-579885755a85a1a52010bcead39edf2b22908b417b5770757318c3ecd0149ff13 |
IEDL.DBID | RPM |
ISSN | 1929-0748 |
IngestDate | Tue Sep 17 21:02:55 EDT 2024 Fri Aug 16 21:31:39 EDT 2024 Fri Aug 23 03:20:25 EDT 2024 Sat Sep 28 08:13:18 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | MLC601 NeuroAiD spinal cord injury MLC901 safety recovery efficacy |
Language | English |
License | Ramesh Kumar, Ohnmar Htwe, Azmi Baharudin, Mohammad Hisam Ariffin, Shaharuddin Abdul Rhani, Kamalnizat Ibrahim, Aishah Rustam, Robert Gan. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 05.12.2016. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c314t-579885755a85a1a52010bcead39edf2b22908b417b5770757318c3ecd0149ff13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0317-0374 0000-0002-2356-690X 0000-0001-5200-8395 0000-0003-1691-9102 0000-0003-3626-2451 0000-0001-6303-9859 0000-0002-9810-3184 0000-0002-4979-9031 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168536/ |
PMID | 27919862 |
PQID | 1846371101 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5168536 proquest_miscellaneous_1846371101 crossref_primary_10_2196_resprot_6275 pubmed_primary_27919862 |
PublicationCentury | 2000 |
PublicationDate | 20161205 |
PublicationDateYYYYMMDD | 2016-12-05 |
PublicationDate_xml | – month: 12 year: 2016 text: 20161205 day: 5 |
PublicationDecade | 2010 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada – name: Toronto, Canada |
PublicationTitle | JMIR research protocols |
PublicationTitleAlternate | JMIR Res Protoc |
PublicationYear | 2016 |
Publisher | JMIR Publications |
Publisher_xml | – name: JMIR Publications |
References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref9 doi: 10.1016/j.neuropharm.2011.05.003 – ident: ref28 doi: 10.1111/ijs.12324 – ident: ref2 doi: 10.1016/j.pneurobio.2013.11.002 – ident: ref33 doi: 10.1159/000155220 – ident: ref39 – ident: ref35 doi: 10.1159/000126919 – ident: ref6 doi: 10.1038/sj.sc.3102009 – ident: ref25 doi: 10.1159/000247001 – ident: ref37 doi: 10.1007/s11655-014-1687-8 – ident: ref3 doi: 10.1038/sc.2012.137 – ident: ref20 doi: 10.1159/000346231 – ident: ref36 doi: 10.1159/000313398 – ident: ref8 doi: 10.1016/j.neuropharm.2010.01.001 – ident: ref11 doi: 10.1159/000346228 – ident: ref12 doi: 10.1016/j.neuroscience.2014.06.047 – ident: ref19 – ident: ref23 doi: 10.3969/j.issn.1673-5374 – ident: ref26 doi: 10.1111/j.1747-4949.2009.00237.x – ident: ref24 doi: 10.1016/j.ejim.2011.01.002 – ident: ref32 doi: 10.1155/2012/506387 – ident: ref10 doi: 10.1016/j.neuropharm.2012.05.035 – ident: ref18 doi: 10.1111/ijs.12044 – ident: ref22 doi: 10.4061/2011/721613 – ident: ref34 – ident: ref15 – ident: ref4 doi: 10.1038/sj.sc.3102007 – ident: ref13 doi: 10.1007/s11481-014-9570-0 – ident: ref30 doi: 10.1161/STROKEAHA.113.003226 – ident: ref31 doi: 10.1159/000382082 – ident: ref38 – ident: ref21 doi: 10.1161/STROKEAHA.108.531616 – ident: ref29 doi: 10.1016/j.jstrokecerebrovasdis.2014.11.017 – ident: ref1 doi: 10.1038/sc.2012.158 – ident: ref5 doi: 10.1038/sj.sc.3102008 – ident: ref17 doi: 10.1159/000346234 – ident: ref7 doi: 10.1038/sj.sc.3102010 – ident: ref16 – ident: ref27 doi: 10.1161/STROKEAHA.113.002055 – ident: ref14 |
SSID | ssj0000877926 |
Score | 2.0506415 |
Snippet | Spinal cord injury (SCI) is a devastating condition with limited therapeutic options despite decades of research. Current treatment options include use of... BACKGROUNDSpinal cord injury (SCI) is a devastating condition with limited therapeutic options despite decades of research. Current treatment options include... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | e230 |
SubjectTerms | Original Paper |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEBZpAqWX0CRts_0JU2igPThYlmTZgVKWNCEtJIQ6S3Mzsi2ThNROdzfQveUh-oR9hD5BZyTvNpvtqTeD9WNJn6RvmPE3jL0J05prW6UBr2MbSI5PqUhVIMLIVlGNd0rpAmSP48OB_HymzpbYNNtoN4Gjf5p2lE9qMLza-fF98gE3_HsKY0YAkco2iRrskODuA7YSSSEJ60cd0XdncqJ1GsU-8n2hEikC6xTN7ziav54WOOf90Mk7d9HBY7bakUjo-1VfY0u2WWcPjzo3-Qb7nV1TsivYQ8sSPjWXOG-_bn96_y5eVXDaXtmhF-iegGkqGIwstDWW_4aGsq3gy5x-tyviVDz6Fx_hbUahEsdAEYiTd7twguNrEU7UQL8BH9TnfPe-CH4A_O0a-SZkprZdx_ukYGHKCVWe9dCnBEijMZy46Hb4et5C5v_zgszi1sMWFsb3hA0O9k_3DoMuuUNQCi7HgSKhNOSKyiTKcKPIK1-UiGuR2qqOCtKhTwrJdaG0Rl6j8fAphS0rsunqmounbLlpG7vJQIm4ipAqRjIJZYmUKilCboi6JdKkWvTY9nRN82uv4ZGj7UMwyDsY5ASDHns9XfAcNxl5Tkxj25tRjmZwLDQyJd5jzzwAZi1NkdNjeg4aswIk4D3_prk4d0LeisfIluLn_13zBXuE8-YSKYXqJVseD2_sKyRJ42LL4f8PkVwY2g priority: 102 providerName: Scholars Portal |
Title | Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27919862 https://search.proquest.com/docview/1846371101 https://pubmed.ncbi.nlm.nih.gov/PMC5168536 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtNAEF61RUJcUPkPhWiQQIKDE6_X67W5hZCqICWK6kbkZtnrtRrU2FGTHnLjIXhCHoEnYGZth4beuFiWvN61vTOebzyfv2XsrRsVXJk8cngRGMfnuBeJSDrC9UzuFRhTtCXIToKzmf91LucHTLb_wljSvs4WvfJq2SsXl5ZbuVrqfssT60_HQ8kDjDJB_5AdKiFupej29RsqFXlBTXJHfwxIhZtED3okyEvivyrCTDvw9iPRHXj5L0vyVtg5PWYPG7wIg_q6HrEDUz5m98dNRfwJ-x2vaF0rGGISCV_K7_iIfv34WZdyMSrBRXVlrmst7i2kZQ6ztYGqwPZLzIlNDud7Ut22iRXsGCw-w_uYWBETILLh9sNHmOL9VWg51MGghJq_Z8v0dRO8APg7NEJLiNPCNAOPSKwi1Vs6eTfCgNY6Wm9gaons8O2ygrj-pQtig16GPdy5v6dsdjq6GJ45zToOjhbc3ziSNNEQFso0lClPJRXgM40mLCKTF15GkvNh5nOVSaUQwih8z2hhdE7pW1Fw8YwdlVVpXjDAWc89RIWeH7q-RvQUZi5PCaWFfhop0WHv2jlNVrVcR4JpDplB0phBQmbQYW_aCU_Qn6hIkpamulknmPEGQiEo4h32vDaAXU-t5XSY2jONXQPS6t4_giZsNbsbk33532eesAf43OyaSa58xY421zfmNeKhTdZFL5gr3IZD3mX3Po0m0_Ou_baA27Efdq1__AFzPhYn |
link.rule.ids | 230,315,733,786,790,870,891,2236,24346,27957,27958,31755,33302,33780,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXGkIAXvmHl00ggwUPSOInjhLeqbOpgrSrSwt6ixHG0jjWp1vShPPEj-IX8BH4B99pJWbcneIsUx46tc3PPlU-OCXntRAUTKo8sVgTK8hlcRV7ELc9xVe4WkFOkFsiOgsHU_3jMj3cIb_-F0aJ9mc3s8mxul7MTra1czGW31Yl1x8M-ZwFkmaB7jVyHeHXFhSJdf4BDISI3MDJ3iMgAfbjR9sBGS160_xUR1NqBu52LrhDMyzrJC4nn4A750r6y0Zt8s1d1Zsvvl9wc_3lOd8nthorSnrl9j-yo8j65MWw22x-Q3_ECj8yifahP6WF5Cqv_68dPs0sMCY9OqjN1bmy-1zQtczpdKloV0H4O5bbK6ectF3DdRHuB9GYf6NsYBRcjijrG9bv3dAwLVwEosYNeSY00UCsATBN4Afp3aGCtNE4L1Qy8jz4YqVzjw5sReniM0rKmY62Rp19PKhqbv8VorCCAoYcr83tIpgf7k_7Aao6IsKTH_NriaLcGjJOnIU9ZynFvP5MQHV6k8sLN0M0-zHwmMi4EsCMBnzDpKZljZVgUzHtEdsuqVHuEwuLnLhBO1w8dXwIxCzOHpUgAQz-NhNchb1qwJAvjBJJABYX4Shp8JYivDnnVIimBUMX9l7RU1WqZQDEdeAL4FuuQxwZZm55aSHaI2MLcpgHagG_fASRpO_AGOU_--8mX5OZgMjxKjg5Hn56SW7CG-mgmhz8ju_X5Sj0H2lVnL3SQ_QHtzTME |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFB1BkSo2vB_heZFAgoUdj19js4vSRi3QKMKNqLqx7PFYDTR21CSLsOIj-EI-gS_g3hk7JO2uu0gZz_hxru-5muNzGXvrxCUXqogtXobK8jn-ir04sDzHVYVbYk6RWiA7DA_G_qeT4GSj1ZcW7ct8YlfnU7uanGlt5Wwqu61OrDs66gc8xCwTdmdF2b3JbmHMuvFGoa5fwpEQsRsaqTtGZUhe3GR9YJMtL1kAixjr7dDdzkdXSOZlreRG8hncZaftaRvNyQ97ucht-fOSo-O1ruseu9NQUuiZIffZDVU9YLtHzab7Q_Y3mVHrLOhjnQqH1Xd8Cn9-_Ta7xZj44Lg-VxfG7nsFWVXAeK6gLnH8FMtuVcDXLTdwPUR7gvQme_A-IeHFEEjPuPrwEUZ482oEJ03Qq8BIBLUSwAzBE4D_SyN7hSQrVbPwPvlhZHJFB69X6FE7pfkCRlorD9_OakjMV2OQKAxknOHK9T1i48H-cf_AalpFWNLj_sIKyHYNmWeQRUHGs4D2-HOJUeLFqijdnFzto9znIg-EQJYk8FUmPSULqhDLknuP2U5VV-opA3wAhYvE0_Ujx5dI0KLc4RkRwcjPYuF12LsWMOnMOIKkWEkRxtIGYylhrMPetGhKMWRpHyarVL2cp1hUh55A3sU77IlB13qmFpYdJrZwtx5AduDb_yCatC14g55n1z7yNdsd7Q3SL4fDz8_ZbbyFukOTE7xgO4uLpXqJ7GuRv9Jx9g9SSzWE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spinal+Cord+Injury%E2%80%94Assessing+Tolerability+and+Use+of+Combined+Rehabilitation+and+NeuroAiD+%28SATURN+Study%29%3A+Protocol+of+An+Exploratory+Study+In+Assessing+the+Safety+and+Efficacy+of+NeuroAiD+Amongst+People+Who+Sustain+Severe+Spinal+Cord+Injury&rft.jtitle=JMIR+research+protocols&rft.au=Kumar%2C+Ramesh&rft.au=Htwe%2C+Ohnmar&rft.au=Baharudin%2C+Azmi&rft.au=Ariffin%2C+Mohammad+Hisam&rft.date=2016-12-05&rft.pub=JMIR+Publications&rft.eissn=1929-0748&rft.volume=5&rft.issue=4&rft_id=info:doi/10.2196%2Fresprot.6275&rft_id=info%3Apmid%2F27919862&rft.externalDBID=PMC5168536 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1929-0748&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1929-0748&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1929-0748&client=summon |